An Israeli company has developed a novel diagnostic tool for diabetic patients and is looking for commercial agency or distribution agreements.

CommercialIzraelBOIL20191124001
Offers
Summary: 
A leading Israeli company, specializing in the development, manufacturing and marketing of high quality medical diagnostic kits and systems has a novel test developed to determine the Haptoglobin type, a predictive marker for high risk of developing cardiovascular complications, in human serum. The company is looking for a commercial agency agreement and distribution services agreement, to expand the sales of the test.
Description: 
The company develops, manufactures and markets high quality diagnostic kits and systems for the detection of infectious diseases, genetic screening and other clinical conditions for over 30 years to a network of distributors worldwide. The tests are based upon various immunological and molecular techniques. The company is also the manufacturer of a novel test (ELISA test) developed to determine the Haptoglobin type in human serum. The Haptoglobin (Hp) ELISA is intended for use in diabetic patients only, for the qualitative determination of Hp phenotypes (Hp 1-1, Hp 2-1, or Hp 2-2) in human serum. The test also assesses the beneficial effect of Vitamin E. The test should be used in conjunction with clinical evaluation and patient assessment as an aid in predicting risk of coronary arterial and cardiovascular disease. The company desires for greater sales of their ELISA test for Haptoglobin, through direct collaboration with laboratories, or distributors to expand their sales. The company is seeking a commercial agency agreement or a distribution services agreement to reach a wider market.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
The company is seeking to expand the sales of the Haptoglobin Typing ELISA by locating any potential distributors or through direct contact with any types of partners such as endocrinology or diabetes laboratories, in order for collaboration between the two. The company is open to collaborating with a distributor, with in depth knowledge of the industry, to expand the reach of its product. Additionally, the company is open to establishing a commercial agency agreement, to be represented in an international market.
Stage of Development: 
Already on the market
External code: 
BOIL20191124001